Back to Search
Start Over
Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia
- Source :
- Antimicrobial Agents and Chemotherapy. 55:2693-2695
- Publication Year :
- 2011
- Publisher :
- American Society for Microbiology, 2011.
-
Abstract
- Outcomes for patients with dense bacterial burdens, such as ventilator-associated pneumonia (VAP) patients, are often critically influenced by the adequacy of antimicrobial chemotherapy and by the response of the immune system, particularly the granulocytes. Little information is available about the quantitation of kill of organisms over time by granulocytes. In this investigation, we examined the impact of the baseline bacterial burden on the ability of granulocytes alone (without chemotherapy) to keep the number of organisms in check or to kill them over a 24-h period. Pseudomonas aeruginosa ATCC 27853 was the study organism, and we employed a murine pneumonia model (granulocyte replete) for the study. We found that the ability of the immune system to kill P. aeruginosa was saturable. The burden at which the system was half saturated was 2.15 × 10 6 ± 2.66 × 10 6 CFU/g. Burdens greater than 10 7 CFU/g demonstrated net growth over 24 h. These findings suggest the need for aggressive chemotherapy early in the treatment of VAP to keep the burden from saturating the granulocytes. This should optimize the outcome for these seriously infected patients.
- Subjects :
- Blood Bactericidal Activity
medicine.medical_treatment
Biology
Granulocyte
medicine.disease_cause
Microbiology
Mice
Immune system
Antimicrobial chemotherapy
Pneumonia, Bacterial
medicine
Animals
Experimental Therapeutics
Pharmacology (medical)
Pharmacology
Chemotherapy
Pseudomonas aeruginosa
Pneumonia, Ventilator-Associated
medicine.disease
Disease Models, Animal
Pneumonia
Infectious Diseases
medicine.anatomical_structure
Murine model
Immunology
Female
Granulocytes
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 55
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....3d5c32e454328af335e6a4186fba7d6f